Increasing the dose intensity of alemtuzumab (CAMPATH-1H) in chronic lymphocytic leukemia (CLL): The CAM1515 study

被引：0
|
作者：
Dyer, MJS
Buckby, E
Fermahan, P
Walewska, R
Kennedy, B
机构：
[1] Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England
[2] Univ Leicester, Dept Haematol, Leicester, Leics, England
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2959
引用
收藏
页码：830A / 830A
页数：1
相关论文
共 50 条
  • [1] Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia
    L Alinari
    R Lapalombella
    L Andritsos
    R A Baiocchi
    T S Lin
    J C Byrd
    Oncogene, 2007, 26 : 3644 - 3653
  • [2] Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia
    Alinari, L.
    Lapalombella, R.
    Andritsos, L.
    Baiocchi, R. A.
    Lin, T. S.
    Byrd, J. C.
    ONCOGENE, 2007, 26 (25) : 3644 - 3653
  • [3] Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia
    Lin, TS
    Flinn, IW
    Lucas, MS
    Porcu, P
    Sickler, J
    Moran, ME
    Lucas, DM
    Heerema, NA
    Grever, MR
    Byrd, JC
    LEUKEMIA, 2005, 19 (07) : 1207 - 1210
  • [4] Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia
    T S Lin
    I W Flinn
    M S Lucas
    P Porcu
    J Sickler
    M E Moran
    D M Lucas
    N A Heerema
    M R Grever
    J C Byrd
    Leukemia, 2005, 19 : 1207 - 1210
  • [5] Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
    Lundin, J
    Kimby, E
    Bjorkholm, M
    Celsing, F
    Hale, G
    Hjalmar, V
    Merup, M
    Petrescu, A
    Tullgren, O
    Waldmann, H
    Mellstedt, H
    Osterborg, A
    BLOOD, 2001, 98 (11) : 772A - 772A
  • [6] Campath-1H for chronic lymphocytic leukemia
    Rai, KR
    CLINICAL LYMPHOMA, 2002, 3 (02): : 73 - 74
  • [7] CAMPATH-1H therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
    Lundin, J
    Björkholm, M
    Celsing, F
    Hale, G
    Hjalmar, V
    Kimby, E
    Tullgren, O
    Waldman, H
    Mellstedt, H
    Österborg, A
    ANNALS OF ONCOLOGY, 2000, 11 : 96 - 96
  • [8] CAMPATH-1H therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
    Mellstedt, H
    Österborg, A
    Lundin, J
    Björkholm, M
    Celsing, F
    Hagberg, H
    Hast, R
    Hjalmar, V
    Kimby, E
    Luthman, M
    Tullgren, O
    Werner, B
    BLOOD, 1998, 92 (10) : 490A - 490A
  • [9] Purging "in vivo" with alemtuzumab (Campath-1H) before autologous stem cell transplantation (ASCT) in chronic lymphocytic leukemia (CLL)
    Montillo, M
    Tedeschi, A
    Cairoli, R
    Miqueleiz, S
    Scarpati, B
    Cafro, AM
    Intropido, L
    Farioli, R
    Veronese, S
    Morra, E
    BLOOD, 2005, 106 (11) : 821A - 822A
  • [10] Clinical effects of alemtuzumab (Campath-1H) in B-cell chronic lymphocytic leukemia
    Osterborg, A
    Mellstedt, H
    Keating, M
    MEDICAL ONCOLOGY, 2002, 19 (Suppl 2) : S21 - S26
12345